Status:
COMPLETED
Prospective Evaluation of Bleeding Risk of Anticoagulant and Anti-platelet Therapy
Lead Sponsor:
Pain Management Center of Paducah
Conditions:
Bleeding
Eligibility:
All Genders
18+ years
Brief Summary
This study will evaluate bleeding risk and differences in outcomes in patients receiving and not receiving anticoagulant or antiplatelet therapy
Detailed Description
1. To evaluate bleeding risk in interventional procedures in patients with or without antiplatelet and/or anticoagulant therapy. 2. To evaluate differences in outcomes in patients not receiving any an...
Eligibility Criteria
Inclusion
- Subjects undergoing interventional techniques. Subjects who were able to give voluntary, written informed consent.
Exclusion
- All those things, patients on heparin, dextran, and low molecular heparin
Key Trial Info
Start Date :
February 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
12000 Patients enrolled
Trial Details
Trial ID
NCT00625248
Start Date
February 1 2008
End Date
January 1 2010
Last Update
June 24 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pain Management Center of Paducah
Paducah, Kentucky, United States, 42003